Report Detail
Global (United States, European Union and China) Gastrointestinal Therapeutics and Diagnostics Market Research Report 2019-2025
- RnM3623300 |
- 29 July, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.
In 2019, the market size of Gastrointestinal Therapeutics and Diagnostics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Gastrointestinal Therapeutics and Diagnostics.
This report studies the global market size of Gastrointestinal Therapeutics and Diagnostics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Gastrointestinal Therapeutics and Diagnostics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbott Laboratories
Allergan
AstraZeneca
Bayer AG
GlaxoSmithKline
Janssen Pharmaceuticals
Takeda Pharmaceutical
Valeant Pharmaceuticals
Pfizer
AbbVie, Inc.
Market Segment by Product Type
Diagnostics
Therapeutics
Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Gastrointestinal Therapeutics and Diagnostics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Gastrointestinal Therapeutics and Diagnostics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Gastrointestinal Therapeutics and Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Diagnostics
- 1.3.3 Therapeutics
- 1.4 Market Segment by Application
- 1.4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacies
- 1.4.3 Retail Pharmacies
- 1.4.4 Online Pharmacies
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size
- 2.1.1 Global Gastrointestinal Therapeutics and Diagnostics Revenue 2014-2025
- 2.1.2 Global Gastrointestinal Therapeutics and Diagnostics Sales 2014-2025
- 2.2 Gastrointestinal Therapeutics and Diagnostics Growth Rate by Regions
- 2.2.1 Global Gastrointestinal Therapeutics and Diagnostics Sales by Regions 2014-2019
- 2.2.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Gastrointestinal Therapeutics and Diagnostics Sales by Manufacturers
- 3.1.1 Gastrointestinal Therapeutics and Diagnostics Sales by Manufacturers 2014-2019
- 3.1.2 Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Gastrointestinal Therapeutics and Diagnostics Revenue by Manufacturers (2014-2019)
- 3.2.2 Gastrointestinal Therapeutics and Diagnostics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
- 3.3 Gastrointestinal Therapeutics and Diagnostics Price by Manufacturers
- 3.4 Key Manufacturers Gastrointestinal Therapeutics and Diagnostics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Gastrointestinal Therapeutics and Diagnostics Market
- 3.6 Key Manufacturers Gastrointestinal Therapeutics and Diagnostics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Diagnostics Sales and Revenue (2014-2019)
- 4.1.2 Therapeutics Sales and Revenue (2014-2019)
- 4.2 Global Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Type
- 4.3 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type
- 4.4 Gastrointestinal Therapeutics and Diagnostics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Gastrointestinal Therapeutics and Diagnostics Sales by Application
6 United States
- 6.1 United States Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Company
- 6.2 United States Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Type
- 6.3 United States Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Application
7 European Union
- 7.1 European Union Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Company
- 7.2 European Union Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Type
- 7.3 European Union Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Application
8 China
- 8.1 China Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Company
- 8.2 China Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Type
- 8.3 China Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Company
- 9.2 Rest of World Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Type
- 9.3 Rest of World Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Application
- 9.4 Rest of World Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Countries
- 9.4.1 Rest of World Gastrointestinal Therapeutics and Diagnostics Sales by Countries
- 9.4.2 Rest of World Gastrointestinal Therapeutics and Diagnostics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Abbott Laboratories
- 10.1.1 Abbott Laboratories Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Gastrointestinal Therapeutics and Diagnostics
- 10.1.4 Gastrointestinal Therapeutics and Diagnostics Product Introduction
- 10.1.5 Abbott Laboratories Recent Development
- 10.2 Allergan
- 10.2.1 Allergan Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Gastrointestinal Therapeutics and Diagnostics
- 10.2.4 Gastrointestinal Therapeutics and Diagnostics Product Introduction
- 10.2.5 Allergan Recent Development
- 10.3 AstraZeneca
- 10.3.1 AstraZeneca Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Gastrointestinal Therapeutics and Diagnostics
- 10.3.4 Gastrointestinal Therapeutics and Diagnostics Product Introduction
- 10.3.5 AstraZeneca Recent Development
- 10.4 Bayer AG
- 10.4.1 Bayer AG Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Gastrointestinal Therapeutics and Diagnostics
- 10.4.4 Gastrointestinal Therapeutics and Diagnostics Product Introduction
- 10.4.5 Bayer AG Recent Development
- 10.5 GlaxoSmithKline
- 10.5.1 GlaxoSmithKline Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Gastrointestinal Therapeutics and Diagnostics
- 10.5.4 Gastrointestinal Therapeutics and Diagnostics Product Introduction
- 10.5.5 GlaxoSmithKline Recent Development
- 10.6 Janssen Pharmaceuticals
- 10.6.1 Janssen Pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Gastrointestinal Therapeutics and Diagnostics
- 10.6.4 Gastrointestinal Therapeutics and Diagnostics Product Introduction
- 10.6.5 Janssen Pharmaceuticals Recent Development
- 10.7 Takeda Pharmaceutical
- 10.7.1 Takeda Pharmaceutical Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Gastrointestinal Therapeutics and Diagnostics
- 10.7.4 Gastrointestinal Therapeutics and Diagnostics Product Introduction
- 10.7.5 Takeda Pharmaceutical Recent Development
- 10.8 Valeant Pharmaceuticals
- 10.8.1 Valeant Pharmaceuticals Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Gastrointestinal Therapeutics and Diagnostics
- 10.8.4 Gastrointestinal Therapeutics and Diagnostics Product Introduction
- 10.8.5 Valeant Pharmaceuticals Recent Development
- 10.9 Pfizer
- 10.9.1 Pfizer Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Gastrointestinal Therapeutics and Diagnostics
- 10.9.4 Gastrointestinal Therapeutics and Diagnostics Product Introduction
- 10.9.5 Pfizer Recent Development
- 10.10 AbbVie, Inc.
- 10.10.1 AbbVie, Inc. Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Gastrointestinal Therapeutics and Diagnostics
- 10.10.4 Gastrointestinal Therapeutics and Diagnostics Product Introduction
- 10.10.5 AbbVie, Inc. Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Gastrointestinal Therapeutics and Diagnostics Sales Channels
- 11.2.2 Gastrointestinal Therapeutics and Diagnostics Distributors
- 11.3 Gastrointestinal Therapeutics and Diagnostics Customers
12 Market Forecast
- 12.1 Global Gastrointestinal Therapeutics and Diagnostics Sales and Revenue Forecast 2019-2025
- 12.2 Global Gastrointestinal Therapeutics and Diagnostics Sales Forecast by Type
- 12.3 Global Gastrointestinal Therapeutics and Diagnostics Sales Forecast by Application
- 12.4 Gastrointestinal Therapeutics and Diagnostics Forecast by Regions
- 12.4.1 Global Gastrointestinal Therapeutics and Diagnostics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Gastrointestinal Therapeutics and Diagnostics. Industry analysis & Market Report on Gastrointestinal Therapeutics and Diagnostics is a syndicated market report, published as Global (United States, European Union and China) Gastrointestinal Therapeutics and Diagnostics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Gastrointestinal Therapeutics and Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
